Furthermore, BIOiSIM was an ML-based simulation program for pulmonary hypertension remedies with Angiotensin-Converting Enzyme (ACE) and calcium channel blockers (CCB) aimed at repurposing and new drug discovery for SARS-CoV-2 [160]. The gene discussed is ACE; the disease is pulmonary hypertension.